Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MCL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
HNRNPA0 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
REL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATF3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BACH2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EPSTI1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRRG4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SRPK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPTLC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGLV@ - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STX12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TIA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PATL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MEF2C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CXCR4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MXD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADGRF4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BBX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on